Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Oncoplastic breast surgery does not delay the onset of adjuvant chemotherapy: a population-based study

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Incidence and survival of hypopharyngeal cancer: a Danish Nation-Wide Study from 1980 to 2014

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. NTCP model validation method for DAHANCA patient selection of protons versus photons in head and neck cancer radiotherapy

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. An investigative expansion of a competing risk model for first failure site in locally advanced non-small cell lung cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Dexamethasone Dose and Early Postoperative Recovery after Mastectomy: A Double-blind, Randomized Trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND: Only a few studies of limited size have examined whether oncoplastic breast surgery delays the onset of adjuvant chemotherapy as compared to conventional breast surgery. We investigated whether oncoplastic breast surgery causes a delay in the onset of adjuvant chemotherapy in comparison to lumpectomy and mastectomy.

MATERIAL AND METHODS: The study is a population-based cohort study. Within the nationwide registry of the Danish Breast Cancer Group (DBCG), we identified 1798 patients who received adjuvant chemotherapy following mastectomy, lumpectomy or oncoplastic breast surgery for early and unilateral invasive breast cancer. Women treated with neoadjuvant chemotherapy were excluded.

RESULTS: We found no significant difference between the three groups (mastectomy, lumpectomy, oncoplastic breast surgery) in the time from biopsy to surgery (mean time 17.9, 17.0 and 18.3 days, respectively), the time from surgery to onset of adjuvant chemotherapy, nor total time from biopsy to the onset of adjuvant chemotherapy (mean time 52.7, 51.9 and 53.2 days, respectively).

CONCLUSIONS: Our study shows that oncoplastic breast surgery does not delay the onset of adjuvant chemotherapy in comparison with mastectomy and lumpectomy. Accordingly, patients should not be excluded from treatment with oncoplastic breast surgery due to concerns of delay in adjuvant chemotherapy.

Original languageEnglish
JournalActa oncologica
Volume56
Issue number5
Pages (from-to)719-723
Number of pages5
ISSN0284-186X
DOIs
Publication statusPublished - May 2017

    Research areas

  • Journal Article

ID: 52152458